Please use this identifier to cite or link to this item:
Title: Analysis of corrections following regulatory inspections
Authors: Debono, Andrew
Attard Pizzuto, Maresca
Zarb Adami, Maurice
Azzopardi, Lilian M.
Keywords: Pharmaceutical industry -- Malta -- Quality control
Pharmaceutical industry -- European Union countries -- Quality control
Pharmaceutical industry -- Inspection
Issue Date: 2018-03
Publisher: University of Malta. Department of Pharmacy
Citation: Debono, A., Attard Pizzuto, M., Zarb Adami, M., & Azzopardi, L. M. (2018, March). Analysis of corrections following regulatory inspections. Poster session presented at the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain.
Abstract: A poster presentation regarding the analysis of corrections following regulatory inspections. Introduction: A good quality system ensures that the medicinal product’s quality is maintained throughout the whole lifecycle, safeguarding patient’s well-being. The European Union (EU) lays down directives for Member States to ensure that quality levels are achieved. GMP and GDP inspections are undertaken by regulatory agencies to ensure compliance with the EU Directives. Aims: To analyse the corrections resulting from GMP/GDP regulatory inspections carried out by the regulatory authority on manufacturers and wholesalers.
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Analysis_of_corrections_following_regulatory_inspections_2018.pdf317.81 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.